|
LIPT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.778150E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.400300E-02 |
| Normal-vs-Stage2 |
7.679200E-01 |
| Normal-vs-Stage3 |
1.007620E-02 |
| Normal-vs-Stage4 |
1.612430E-04 |
| Stage1-vs-Stage2 |
3.394800E-01 |
| Stage1-vs-Stage3 |
3.528800E-01 |
| Stage1-vs-Stage4 |
1.786260E-02 |
| Stage2-vs-Stage3 |
1.690770E-01 |
| Stage2-vs-Stage4 |
3.826200E-02 |
| Stage3-vs-Stage4 |
2.161400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.634220E-02 |
| Normal-vs-AfricanAmerican |
1.813010E-04 |
| Normal-vs-Asian |
1.737580E-01 |
| Caucasian-vs-AfricanAmerican |
1.265890E-02 |
| Caucasian-vs-Asian |
6.724600E-01 |
| AfricanAmerican-vs-Asian |
6.520400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.558020E-02 |
| Normal-vs-Female |
4.361600E-02 |
| Male-vs-Female |
7.363200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.829800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.911820E-02 |
| Normal-vs-Age(61-80Yrs) |
2.699900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.287000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.452300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.730300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.170590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.049000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.292600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.481000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.633500E-02 |
| Normal-vs-Grade 2 |
4.048200E-01 |
| Normal-vs-Grade 3 |
1.678220E-03 |
| Normal-vs-Grade 4 |
3.20559999988923E-07 |
| Grade 1-vs-Grade 2 |
1.380800E-01 |
| Grade 1-vs-Grade 3 |
8.812400E-01 |
| Grade 1-vs-Grade 4 |
1.956810E-01 |
| Grade 2-vs-Grade 3 |
6.481500E-03 |
| Grade 2-vs-Grade 4 |
4.64820000045663E-07 |
| Grade 3-vs-Grade 4 |
5.920300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.245600E-01 |
| Normal-vs-ccB subtype |
7.977300E-04 |
| ccA subtype-vs-ccB subtype |
2.27119999999248E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.754400E-02 |
| Normal-vs-N1 |
4.419700E-03 |
| N0-vs-N1 |
3.738000E-02 |
|
|
